The effects of non-compliance on intent-to-treat analysis of equivalence trials

被引:28
|
作者
Sheng, D
Kim, MY
机构
[1] NYU, Dept Environm Med, Sch Med, Div Biostat, New York, NY 10016 USA
[2] Albert Einstein Coll Med, Div Biostat, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA
关键词
non-compliance; equivalence trials; non-inferiority trials; intent-to-treat;
D O I
10.1002/sim.2230
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The standard approach for analysing a randomized clinical trial is based on intent-to-treat (ITT) where subjects are analysed according to their assigned treatment group regardless of actual adherence to the treatment protocol. For therapeutic equivalence trials, it is a common concern that an ITT analysis increases the chance of erroneously concluding equivalence. In this paper, we formally investigate the impact of non-compliance on an ITT analysis of equivalence trials with a binary outcome. We assume 'all-or-none' compliance and independence between compliance and the outcome. Our results indicate that non-compliance does not always make it easier to demonstrate equivalence. The direction and magnitude of changes in the type I error rate and power of the study depend on the patterns of noncompliance, event probabilities, the margin of equivalence and other factors. Copyright (c) 2005 John Wiley & Sons, Ltd.
引用
收藏
页码:1183 / 1199
页数:17
相关论文
共 50 条
  • [1] On estimating treatment effects under non-compliance in randomized clinical trials: Are intent-to-treat or instrumental variables analyses perfect solutions?
    Bang, Heejung
    Davis, Clarence E.
    STATISTICS IN MEDICINE, 2007, 26 (05) : 954 - 964
  • [2] Intent-to-treat analysis for longitudinal clinical trials: coping with the challenge of missing values
    Mazumdar, S
    Liu, KS
    Houck, PR
    Reynolds, CF
    JOURNAL OF PSYCHIATRIC RESEARCH, 1999, 33 (02) : 87 - 95
  • [3] Assumption-Lean Analysis of Cluster Randomized Trials in Infectious Diseases for Intent-to-Treat Effects and Network Effects
    Park, Chan
    Kang, Hyunseung
    JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2023, 118 (542) : 1195 - 1206
  • [4] Intent-to-treat analysis and preventive vaccine efficacy
    Horne, AD
    Lachenbruch, PA
    Goldenthal, KL
    VACCINE, 2000, 19 (2-3) : 319 - 326
  • [5] Is intent-to-treat analysis always (ever) enough?
    Sheiner, LB
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (02) : 203 - 211
  • [6] Intent-to-Treat in the "cheating" paradigm: a meta-analysis
    Redlich, Allison D. D.
    Catlin, Mary
    Bettens, Talley
    JOURNAL OF EXPERIMENTAL CRIMINOLOGY, 2024, 20 (03) : 665 - 681
  • [7] A critical analysis of the intent-to-treat principle in prevention research
    Gross D.
    Fogg L.
    Journal of Primary Prevention, 2004, 25 (4) : 475 - 489
  • [8] A comparison of intent-to-treat and per-protocol results in antibiotic non-inferiority trials
    Brittain, E
    Lin, D
    STATISTICS IN MEDICINE, 2005, 24 (01) : 1 - 10
  • [9] Intent-to-treat analysis of cluster randomized trials when clusters report unidentifiable outcome proportions
    DeSantis, Stacia M.
    Li, Ruosha
    Zhang, Yefei
    Wang, Xueying
    Vernon, Sally W.
    Tilley, Barbara C.
    Koch, Gary
    CLINICAL TRIALS, 2020, 17 (06) : 627 - 636
  • [10] Choosing the analysis population in non-inferiority studies: Per protocol or intent-to-treat
    Sanchez, MM
    Chen, X
    STATISTICS IN MEDICINE, 2006, 25 (07) : 1169 - 1181